• Saffron Therapeutics
  • Saffron Therapeutics
  • Saffron Therapeutics

Five diabetes drugs amongst top selling drugs in the country

21

July

Five anti diabetes drugs are amongst the top ten selling drugs in the country. Control of non-communicable disease has been one of the greatest challenges for the country. This is a major shift from the earlier trend when the organised retail pharma market was dominated by anti infectives and antibiotics.

The anti-diabetic therapy segment is estimated to be worth INR 8500 crore and is growing at a strong rate of 12 percent as per data from AIOCD Awacs. Human Mixtard, Glycomet GP, Lantus, Galvus Met and Janumet are the 5 top selling anti diabetics drugs. The number of diabetes drugs in the top 10 selling drugs has increased from 1 in June 2013 to 5 in June 2016.